Detalles de la búsqueda
1.
Prognostic nutritional index after introduction of atezolizumab with bevacizumab predicts prognosis in advanced hepatocellular carcinoma: A multicenter study.
Oncology
; 2024 Jan 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38237558
2.
Outcome of nucleos(t)ide analog cessation in patients with treatment for prevention of or against hepatitis B virus reactivation.
Hepatol Res
; 53(4): 289-300, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36461885
3.
The neutrophil-to-lymphocyte ratio at the start of the second course during atezolizumab plus bevacizumab therapy predicts therapeutic efficacy in patients with advanced hepatocellular carcinoma: A multicenter analysis.
Hepatol Res
; 53(6): 511-521, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36723964
4.
Long-term outcomes of nasogastric tube with Gastrografin for adhesive small bowel obstruction.
J Gastroenterol Hepatol
; 37(1): 111-116, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34478173
5.
Serum CXCL10 levels at the start of the second course of atezolizumab plus bevacizumab therapy predict therapeutic efficacy in patients with advanced BCLC stage C hepatocellular carcinoma: A multicenter analysis.
Cancer Med
; 2023 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38133557
6.
The first management using intubation of a nasogastric tube with Gastrografin enterography or long tube for non-strangulated acute small bowel obstruction: a multicenter, randomized controlled trial.
J Gastroenterol
; 55(9): 858-867, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32671536
Resultados
1 -
6
de 6
1
Próxima >
>>